Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Pharma Mar (0RC6)

Pharma Mar Sa
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0RC6
DateTimeSourceHeadlineSymbolCompany
04/06/202408:00PR Newswire (US)PharmaMar presents encouraging results at ASCO for Small Cell Lung CancerLSE:0RC6Pharma Mar Sa
11/01/202214:13PR Newswire (US)Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variantsLSE:0RC6Pharma Mar Sa
11/01/202214:09PR Newswire (US)Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variantsLSE:0RC6Pharma Mar Sa
22/12/202110:17PR Newswire (US)PharmaMar signs a new licensing and commercialization agreement with Eczacibasi for lurbinectedin in TurkeyLSE:0RC6Pharma Mar Sa
13/12/202113:39PR Newswire (US)PharmaMar and Jazz Pharmaceuticals announce initiation of confirmatory phase III clinical trial of Zepzelca® (lurbinectedin) for the treatment of patients with relapsed Small Cell Lung CancerLSE:0RC6Pharma Mar Sa
11/11/202112:39PR Newswire (US)PharmaMar signs a licensing and commercialization agreement with Lotus Pharmaceutical for lurbinectedin in TaiwanLSE:0RC6Pharma Mar Sa
28/04/202011:39PR Newswire (US)PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitid...LSE:0RC6Pharma Mar Sa
28/04/202011:35PR Newswire (US)PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitid...LSE:0RC6Pharma Mar Sa
 Showing the most relevant articles for your search:LSE:0RC6